EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

L26/P-246 Microfluidic versus conventional sperm selection in ICSI with PGT-A: a systematic review and meta-analysis of embryo euploidy and clinical outcomes

S. Bose, P. Penido, L. Estrella, A. Floriano, A. Chukwudi

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.582 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von S. Bose und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Does microfluidic sperm selection improve blastocyst euploidy rates compared with conventional sperm preparation methods in ICSI cycles? Summary answer Microfluidic sperm selection was associated with a modest but statistically significant increase in blastocyst euploidy compared with conventional sperm preparation methods. What is known already Sperm DNA fragmentation is associated with impaired fertilisation, abnormal embryo development, and increased embryo aneuploidy. Conventional sperm preparation techniques, including density-gradient centrifugation and swim-up, may exacerbate oxidative stress through centrifugation. Microfluidic sperm selection is a non-centrifugation-based method designed to isolate highly motile spermatozoa with improved genomic integrity and reduced reactive oxygen species. Emerging studies suggest that microfluidic selection may reduce sperm DNA fragmentation and improve fertilisation or implantation outcomes. However, evidence regarding its impact on embryo chromosomal competence assessed by PGT-A remains inconsistent, limited by small sample sizes, heterogeneous populations, and variable study designs. Study design, size, duration This systematic review and meta-analysis evaluated comparative studies of microfluidic versus conventional sperm preparation on embryo chromosomal competence in ICSI cycles undergoing PGT-A. RCTs, sibling-oocyte studies, and prospective or retrospective cohorts were included. Embryo- and cycle-level outcomes were synthesised using random-effects models, with statistical methods accounting for paired designs and clustering within women. Nine full-text studies published between 2019 and 2025 were included, encompassing both randomised and observational evidence.The primary outcome was blastocyst-level euploidy. Participants/materials, setting, methods Eligible studies included ICSI cycles with preimplantation genetic testing for aneuploidy comparing microfluidic sperm sorting with conventional preparation methods (density-gradient centrifugation and/or swim-up). Data were extracted on embryo-level genetic outcomes and post-transfer clinical outcomes across full-text comparative studies. Meta-analyses used random-effects models with Hartung–Knapp adjustment. Paired sibling-oocyte designs and clustering within women were accounted for using robust variance estimation or effective sample-size correction. Main results and the role of chance Across nine comparative studies including more than 4,500 biopsied blastocysts, microfluidic sperm selection was associated with a significantly higher likelihood of blastocyst euploidy compared with conventional sperm preparation methods (random-effects OR 1.17, 95% CI 1.04–1.31; p = 0.011). Between-study heterogeneity was low (I² ≤ 25%), indicating consistency of effect across heterogeneous study designs and populations. This association was observed for the primary outcome of euploidy rate per blastocyst biopsied. Secondary embryological outcomes, including aneuploidy and mosaicism rates, fertilisation, blastulation efficiency, and blastocyst yield, were variably reported and therefore not pooled quantitatively. Similarly, clinical outcomes following euploid embryo transfer; implantation, clinical pregnancy, ongoing pregnancy, live birth, and pregnancy loss were inconsistently assessed across studies, precluding meta-analysis. Overall, the observed improvement in embryo chromosomal competence associated with microfluidic sperm selection is unlikely to be explained by chance alone and was evident across diverse study designs, patient populations, and PGT-A strategies, supporting a modest but consistent association with improved euploidy outcomes.Importantly, the direction of effect was consistent across randomized sibling-oocyte trials and observational cohorts, despite differences in patient selection and comparator methods. Limitations, reasons for caution Included studies varied in design, patient selection, and reporting of secondary and clinical outcomes. Several were observational and underpowered for clinical endpoints. Embryo-level analyses required adjustment for multiple embryos per woman, which may slightly affect precision. Wider implications of the findings Microfluidic sperm selection is associated with a modest improvement in embryo euploidy in unselected IVF populations, with potentially greater clinical relevance in male-factor infertility. These findings support a targeted, indication-driven approach rather than routine universal use, pending confirmation from adequately powered randomized trials. Trial registration number Yes

Zitieren

APA

Bose, S., Penido, P., Estrella, L., Floriano, A., & Chukwudi, A. (2026). L26/P-246 Microfluidic versus conventional sperm selection in ICSI with PGT-A: a systematic review and meta-analysis of embryo euploidy and clinical outcomes. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.582

Vancouver

Bose S, Penido P, Estrella L, Floriano A, Chukwudi A. L26/P-246 Microfluidic versus conventional sperm selection in ICSI with PGT-A: a systematic review and meta-analysis of embryo euploidy and clinical outcomes. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.582

BibTeX
@article{Bose2026,
  author = {Bose, S. and Penido, P. and Estrella, L. and Floriano, A. and Chukwudi, A.},
  title = {L26/P-246 Microfluidic versus conventional sperm selection in ICSI with PGT-A: a systematic review and meta-analysis of embryo euploidy and clinical outcomes},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.582}
}
Kostenlos starten →